IKT
Price
$1.57
Change
+$0.06 (+3.97%)
Updated
Oct 17 closing price
Capitalization
116.99M
SNDX
Price
$14.30
Change
-$0.75 (-4.98%)
Updated
Oct 17 closing price
Capitalization
1.23B
24 days until earnings call
Interact to see
Advertisement

IKT vs SNDX

Header iconIKT vs SNDX Comparison
Open Charts IKT vs SNDXBanner chart's image
Inhibikase Therapeutics
Price$1.57
Change+$0.06 (+3.97%)
Volume$217.28K
Capitalization116.99M
Syndax Pharmaceuticals
Price$14.30
Change-$0.75 (-4.98%)
Volume$4.38M
Capitalization1.23B
IKT vs SNDX Comparison Chart in %
IKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IKT vs. SNDX commentary
Oct 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IKT is a Hold and SNDX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 18, 2025
Stock price -- (IKT: $1.57 vs. SNDX: $14.30)
Brand notoriety: IKT and SNDX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IKT: 179% vs. SNDX: 198%
Market capitalization -- IKT: $116.99M vs. SNDX: $1.23B
IKT [@Biotechnology] is valued at $116.99M. SNDX’s [@Biotechnology] market capitalization is $1.23B. The market cap for tickers in the [@Biotechnology] industry ranges from $106.87B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IKT’s FA Score shows that 1 FA rating(s) are green whileSNDX’s FA Score has 1 green FA rating(s).

  • IKT’s FA Score: 1 green, 4 red.
  • SNDX’s FA Score: 1 green, 4 red.
According to our system of comparison, SNDX is a better buy in the long-term than IKT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IKT’s TA Score shows that 3 TA indicator(s) are bullish while SNDX’s TA Score has 4 bullish TA indicator(s).

  • IKT’s TA Score: 3 bullish, 5 bearish.
  • SNDX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, SNDX is a better buy in the short-term than IKT.

Price Growth

IKT (@Biotechnology) experienced а -2.48% price change this week, while SNDX (@Biotechnology) price change was -10.96% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.56%. For the same industry, the average monthly price growth was +15.88%, and the average quarterly price growth was +79.09%.

Reported Earning Dates

SNDX is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+1.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SNDX($1.23B) has a higher market cap than IKT($117M). SNDX YTD gains are higher at: 8.169 vs. IKT (-51.692). IKT has higher annual earnings (EBITDA): -45.66M vs. SNDX (-314.25M). SNDX has more cash in the bank: 469M vs. IKT (87.7M). IKT has less debt than SNDX: IKT (37.9K) vs SNDX (1.68M). SNDX has higher revenues than IKT: SNDX (77.9M) vs IKT (0).
IKTSNDXIKT / SNDX
Capitalization117M1.23B9%
EBITDA-45.66M-314.25M15%
Gain YTD-51.6928.169-633%
P/E RatioN/AN/A-
Revenue077.9M-
Total Cash87.7M469M19%
Total Debt37.9K1.68M2%
FUNDAMENTALS RATINGS
SNDX: Fundamental Ratings
SNDX
OUTLOOK RATING
1..100
66
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
44
P/E GROWTH RATING
1..100
4
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IKTSNDX
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 1 day ago
76%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 1 day ago
82%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 1 day ago
89%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 1 day ago
78%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 16 days ago
83%
Bullish Trend 11 days ago
83%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 6 days ago
78%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 1 day ago
81%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 1 day ago
67%
View a ticker or compare two or three
Interact to see
Advertisement
IKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EMBVF9.770.07
+0.77%
Arca Continental SAB de CV
IFLXF0.77N/A
N/A
Imaflex Inc
PPZRF0.01N/A
N/A
SEASIF EXPLORATION INC.
MRPZF12.02N/A
N/A
Mr. Price Group Ltd.
CHXMF1.04-0.08
-7.47%
Troilus Gold Corp.

IKT and

Correlation & Price change

A.I.dvisor indicates that over the last year, IKT has been loosely correlated with SYRE. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if IKT jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IKT
1D Price
Change %
IKT100%
+3.97%
SYRE - IKT
33%
Loosely correlated
+1.03%
ZNTL - IKT
32%
Poorly correlated
-4.49%
SNDX - IKT
31%
Poorly correlated
-4.98%
VYGR - IKT
31%
Poorly correlated
-7.13%
CGON - IKT
30%
Poorly correlated
-0.93%
More